Chinese Red Yeast Rice Comparison to Lovastatin
$159,181P50FY2002ATNIH
University Of California Los Angeles, Los Angeles CA
Investigators
Linked publications & trials
Paper 28616355Paper 19813713Paper 19188016Paper 18598186Paper 17503006Paper 17498920Paper 17438654Paper 17125240Paper 16988113Paper 16965242Paper 16899616Paper 16820889Paper 16772446Paper 16639733Paper 16448212Paper 16441081Paper 16398595Paper 16365058Paper 16206039Paper 16118406Paper 16111881Paper 16081270Paper 16000511Paper 15994841Paper 15936648Paper 15930295Paper 15856451Paper 15746073Paper 15629237Paper 15586232Paper 15500944Paper 15456636Paper 15369737Paper 15289852Paper 15202006Paper 15113149Paper 15060607Paper 15042410Paper 15026318Paper 14973081Paper 14743185Paper 14645683Paper 14567158Paper 14532991Paper 12972656Paper 12964005Paper 12964003Paper 12855654Paper 12813173Paper 12781698Paper 12772189Paper 12746292Paper 12588089Paper 12234985Paper 12188609Paper 12168090Paper 11962250Paper 11940110Paper 11908756Paper 11741179Paper 11730937Paper 11605065Paper 11526468Paper 11216471
Abstract
Description: This project will evaluate the effect, on cholesterol biosynthesis and atherosclerotic lesion formation, of a mixture of monacolins isolated from a yeast fermented rice compared to Lovastatin. This will be accomplished by measuring up-regulation of HMG-COA gene transcription in HEPG2 cell constructs containing a luciferase reporter gene. A second end point will be the formation of atherosclerotic lesions and measuring blood cholesterol levels in ApoE knockout mice. The final study will assay the bioavailability of the mixture of monacolins from red yeast rice and of pure Lovastatin in human volunteers.
View original record on NIH RePORTER →